What Happens When You Stop Taking Mounjaro for Weight Loss

You've decided to stop — here's what your body is likely to do next

Picture this: you've been on Mounjaro for several months, your appetite has shrunk noticeably, and the weight has come off steadily. Then, for whatever reason (cost, a planned surgery, a pregnancy, or simply feeling you've reached your goal) you take your last injection.

Within a few days, tirzepatide's dual action on GIP and GLP-1 receptors begins to ease. Gastric emptying speeds back up. The fullness signals that made you push a half-eaten plate away start to quiet down. Hunger, the kind that drove you to eat before treatment, tends to reassert itself. For most people this doesn't happen overnight, but it becomes noticeable within two to four weeks of the final dose. That's the physiology, and it's worth reading about what happens to your body when you stop taking Mounjaro before you reach that point, not after.

The NHS's patient information on tirzepatide notes that the medicine works by mimicking hormones involved in appetite and blood-sugar regulation. Once those mimicked signals are gone, the underlying hormonal environment that drove weight gain in the first place hasn't changed. That's not a failure of the medicine; it's how biology works for a condition that has a strong physiological basis. Understanding this is the starting point for any sensible stopping plan, and our guide on what happens when you stop taking Mounjaro is a useful place to build that understanding before you make any decisions. You can read more about how the medicine functions on the Mounjaro injection page.

Weight regain: what the trial data actually say

The clearest evidence comes from extension and withdrawal phases of the large tirzepatide trials. When participants stopped the active medicine and returned to lifestyle measures alone, a meaningful proportion of the weight lost during treatment was regained over the following months. This mirrors what was seen with semaglutide in the STEP 1 extension study, where roughly two-thirds of weight lost returned within a year of stopping, as reported in the STEP 1 trial published in the New England Journal of Medicine.

The pattern for tirzepatide, while studied in the SURMOUNT programme involving thousands of adults, follows the same direction: stopping accelerates weight regain; the degree depends on diet, activity and individual metabolic factors. Some people regain very little if lifestyle changes have become genuinely habitual; others regain most of what they lost. Neither outcome is guaranteed, and a prescriber's job is partly to have that honest conversation before you stop rather than leaving you to find out by accident. Our guide covering what happens when you stop Mounjaro looks at these outcomes in more detail.

If you're weighing up the cost of continuing against the risk of regain, the Mounjaro cost page lays out what private treatment typically involves, including what an all-in price should cover.

Does stopping cause any specific side effects or withdrawal symptoms?

Tirzepatide is not associated with physical dependence or a pharmacological withdrawal syndrome in the way some medicines are. There is no recognised withdrawal effect in the clinical sense. What people commonly describe, though, is a return of the appetite that treatment had suppressed, which can feel dramatic precisely because the contrast with treatment is so striking. Food noise (the intrusive, frequent thoughts about eating that many people on GLP-1-type medicines report disappearing) tends to come back.

Some people also notice that energy levels or mood shift slightly in the weeks after stopping, though this is not a listed adverse effect and may reflect changes in eating patterns rather than any direct pharmacological action. If you're experiencing anything that concerns you after stopping, the right step is to contact the prescriber or clinical team who managed your treatment. Our contact page has details of how to reach our prescriber team. For a broader look at what happens when you stop using Mounjaro, including what to expect physically in the weeks that follow, our dedicated guide covers this in more detail.

Stopping well: what a sensible plan looks like

The prescribers our clinical team works with, including those you can read about on the clinical team page, consistently make the same point: the time to plan stopping is before you stop, not when you've already taken the last pen out of the fridge.

A structured approach usually involves three things. First, a realistic conversation about what lifestyle changes have genuinely stuck versus which ones depended on the medicine suppressing appetite. Second, a clear sense of why stopping now is the right decision, whether that's clinical, personal or financial. Third, agreement on what monitoring looks like afterwards, so that significant regain is caught early rather than after a year has passed.

The NHS's guidance on weight-management medicines, published by NHS England, frames these medicines as one part of a broader lifestyle programme, precisely because the biological drivers of weight don't disappear when treatment stops. Protein adequacy, strength-based activity and maintaining a lower-calorie pattern all become more important once appetite suppression lifts.

If you're thinking about what comes next, whether that's continuing treatment, planning a structured pause or exploring your options for the first time, you can start a free consultation with our prescribers. There's no obligation, and you'll get a clinical view rather than a generic answer.